Chemoinformaics analysis of HEXADECA-7,10,13-TRIENOIC-ACID
| Molecular Weight | 286.412 | nRot | 15 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 2 |
| Exact Molecular Weight | 286.214 | nRing | 0 |
| Solubility: LogS | -3.295 | nHRing | 0 |
| Solubility: LogP | 4.829 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 49.9318 |
| nHD | 2 | BPOL | 31.8322 |
| QED | 0.431 |
| Synth | 1.501 |
| Natural Product Likeliness | 0.281 |
| NR-PPAR-gamma | 0.974 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.022 |
| CACO-2 | -5.51 |
| MDCK | 0.000051 |
| BBB | 0.007 |
| PPB | 0.982335 |
| VDSS | 0.374 |
| FU | 0.00855632 |
| CYP1A2-inh | 0.051 |
| CYP1A2-sub | 0.156 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.1 |
| CYP2c9-sub | 0.992 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.065 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.006 |
| CL | 1.409 |
| T12 | 0.798 |
| hERG | 0.011 |
| Ames | 0.004 |
| ROA | 0.011 |
| SkinSen | 0.505 |
| Carcinogencity | 0.169 |
| EI | 0.973 |
| Respiratory | 0.305 |
| NR-Aromatase | 0.032 |
| Antiviral | Yes |
| Prediction | 0.57311 |